Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
Investor Presentation
Q3 FY18
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Tejnaksh Healthcare Ltd (TEJNAKSH) is currently trading at 12.99 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Tejnaksh Healthcare Limited specializes in urology services, providing comprehensive healthcare solutions through its Institute of Urology in Dhule, Maharashtra. The company transformed from a private to a public entity in 2015, expanding its service offerings and geographic presence in Maharashtra and Madhya Pradesh. Tejnaksh Healthcare prides itself on pioneering initiatives such as North Maharashtra’s first Urodynamics Lab and indigenous PCNL simulation labs. The company's efforts focus on strengthening healthcare in rural India, offering affordable and quality healthcare services with multiple urology clinics and hospitals.
Over the past 52 weeks, Tejnaksh Healthcare Ltd has traded between a low of ₹10.65 and a high of ₹18.88. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Tejnaksh Healthcare Ltd has a market capitalization of approximately 26.41. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Tejnaksh Healthcare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 21.47 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 26.41 Cr, Tejnaksh Healthcare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Tejnaksh Healthcare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Tejnaksh Healthcare Ltd is 21.47. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Tejnaksh Healthcare Limited specializes in urology services, providing comprehensive healthcare solutions through its Institute of Urology in Dhule, Maharashtra.
The company transformed from a private to a public entity in 2015, expanding its service offerings and geographic presence in Maharashtra and Madhya Pradesh.
Tejnaksh Healthcare prides itself on pioneering initiatives such as North Maharashtra’s first Urodynamics Lab and indigenous PCNL simulation labs.
The company's efforts focus on strengthening healthcare in rural India, offering affordable and quality healthcare services with multiple urology clinics and hospitals.
Healthcare Services
Healthcare Service Provider
26 Cr
Low Risk
21.5
63.4
-0.6
1.0
18.88
10.65
Sales CAGR
Profit CAGR
ROE
Bearish
5
Neutral
3
Bullish
6
ROCE
Bearish
37
Neutral
3
Bullish
6
Bearish
32
Neutral
0
Bullish
0
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
11.87 | 29 Cr | 11.61 | 0.27 | 0.00 | 2.26 | 3.18 | 1.70 | ||
85.00 | 28 Cr | 23.51 | 2.18 | 0.00 | 9.06 | 9.88 | 3.61 | ||
37.00 | 28 Cr | -67.41 | 0.00 | 0.00 | 36.33 | -3.29 | -1.93 | ||
13.00 | 26 Cr | 21.47 | 0.97 | 0.00 | 4.52 | 6.35 | 4.09 | ||
11.21 | 26 Cr | -3.00 | 2.23 | 0.00 | -69.43 | -64.75 | -60.71 | ||
2.53 | 19 Cr | -11.91 | 2.29 | 0.00 | -19.73 | -2.32 | -1.12 | ||
12.90 | 18 Cr | 11.95 | 0.26 | 0.00 | 2.51 | 5.93 | 1.79 | ||
| Median: 7 Co. | — | 12.90 | 26 Cr | 11.61 | 0.97 | 0.00 | 2.51 | 3.18 | 1.70 |
